ArticleRespirology case reports2021

Enteral lorlatinib after alectinib as a treatment option in anaplastic lymphoma kinase-positive non-small cell lung cancer with triple problems: carcinomatous meningitis, poor performance status, and dysphagia-a case report.

Kota Sasaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.